Publishing research using ab64740? Please let us know so that we can cite the reference in this datasheet.
ab64740 has been referenced in 1 publication.
Pasmant E et al.SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.Oncogene N/A:N/A (2014).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"